Article Text

PDF
ID: 47: TESTOSTERONE-HCG THERAPY ASSOCIATED WITH RECURRENT DEEP VENOUS THROMBOSIS-PULMONARY EMBOLISM DESPITE ANTICOAGULATION IN A 55 YEAR OLD MAN WITH THROMBOPHILIA
  1. K Lee,
  2. CJ Glueck
  1. Jewish Hospital Cincinnati, Cincinnati, Ohio, United States

Abstract

Background When exogenous testosterone or treatments to elevate testosterone (human chorionic gonadotropin [HCG] or Clomid) are given to men with underlying familial and/or acquired thrombophilia, deep venous thrombosis and pulmonary embolism often occur, and may recur despite adequate anticoagulation if testosterone therapy is continued.

Case Presentation In a 55 year old white male, referred to us because of 4 thrombotic events, 3 despite adequate anticoagulation over a 5 year period, we assessed interactions between thrombophilia, exogenous testosterone therapy, and recurrent thrombosis. In 2009, despite low-normal serum testosterone 334 ng/dl (lower normal limit [LNL] 300 ng/dl.), he was given testosterone (TT) cypionate (50 mg/week) and HCG (500 units/week) for presumed hypogonadism. Ten months later, with supranormal serum T (1385 ng/dl, UNL 827 ng/dl) and estradiol (E2) 45 pg/ml (UNL 41 pg/ml), he had a pulmonary embolus (PE), and was then anticoagulated for 2 years (enoxaparin, then Coumadin). Four years later, on TT-HCG, he had his first deep venous thrombosis (DVT). TT was stopped, HCG continued; he was anticoagulated (enoxaparin, then Coumadin, then apixaban (Eliquis), then fondaparinux (Arixtra)). One year after his first DVT, on HCG, still on Arixtra, he had a second DVT (5/2015), was anticoagulated (enoxaparin+Coumadin), with a Greenfield filter placed, but 8 days later had a second PE. The Lupus anticoagulant was found to be present. After stopping HCG, and maintained on Coumadin, he has been free of further DVT-PE for 6 months.

Conclusion When DVT- PE occur on TT or HCG, in the presence of thrombophilia, TT- HCG should be stopped, lest DVT-PE reoccur despite concurrent anticoagulation.

  • Abdomen

Statistics from Altmetric.com

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.